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Serum antioxidants as predictors of adult
respiratory distress syndrome in patients with sepsis
Adult respiratory distress syndrome (ARDS) can
develop as a complication of various disorders,
including sepsis, but it has not been possible to
identify which of the patients at risk will develop this
serious disorder. We have investigated the ability of
six markers, measured sequentially in blood, to
predict development of ARDS in 26 patients with
sepsis.
At the initial diagnosis of sepsis (6-24 h before the
development of ARDS), serum manganese
superoxide dismutase concentration and catalase
activity were higher in the 6 patients who
subsequently developed ARDS than in 20 patients
who did not develop ARDS. These changes in
antioxidant enzymes predicted the development of
ARDS in septic patients with the same sensitivity,
specificity, and efficiency as simultaneous
assessments of serum lactate dehydrogenase activity
and factor VIII concentration. By contrast, serum
glutathione peroxidase activity and &agr;1Pi-elastase
complex concentration did not differ at the initial
diagnosis of sepsis between patients who did and
did not subsequently develop ARDS, and were not
as effective in predicting the development of ARDS.
Measurement of manganese superoxide
dismutase and catalase, in addition to the other
markers, should facilitate identification of patients at
highest risk of ARDS and allow prospective
treatment.
Introduction
Adult respiratory distress syndrome (ARDS) is an acute
inflammatory process characterised by neutrophil
accumulation and oedema in the lungs and progressive
hypoxaemia.1 ARDS occurs unpredictably as a
complication in patients with sepsis and several other
predisposing disorders. Since many common and diverse
risk factors can lead to the development ofARDS, but do so
only rarely, pretreatment ofevery patient at risk ofARDS is
not practical. Understanding of ARDS is improving and
various interventions that can limit inflammation have
become available, so it has become important to identify
accessible and repeatable markers in at-risk patients that can
predict the development of ARDS. Experimental
treatments could then be prospectively and effectively
assessed in smaller, better-defined groups of patients.
We assessed the abilities of three antioxidant enzymes,
manganese superoxide dismutase, catalase, and glutathione
peroxidase, andthree other potential markers, factor VIII,2,3
lactate dehydrogenase,4 and (Xl Pi-elastase complexes,s,6 to
predict the development of ARDS in patients with sepsis.
Oxidant-antioxidant balance changes inARDS and in other
disease states in which oxygen radicals have been
implicated.7-10 Serum catalase activity is high in patients
with established ARDS, but it is not known whether this
abnormality arises before the development of ARDS, in
which case it could be predictive, or afterwards.
Patients and methods
Written consent was obtained from each patient or a close
relative. The subjects were studied with a protocol approved by our
hospital’s human subjects review committee. Eligible patients
(n = 26) were identified within 8 h of the diagnosis of sepsis, which
was defined as a serious bacterial infection and either a rectal or core
temperature above 39&deg;C or a peripheral leucocyte count of more
than 1-2 x 10’&deg;/L or more than 20% immature neutrophils. For a
diagnosis of sepsis at least one of the following was also required: a
positive blood culture ofa commonly accepted pathogen, a strongly
suspected or proven source of systemic infection, large amounts of
pus in a closed space, unexplained systemic arterial hypotension
(systolic pressure below 80 mm Hg), systemic vascular resistance
less than 800 dyne s cm2, or unexplained metabolic acidosis."
Criteria for ARDS were acute respiratory failure requiring
mechanical ventilation, bilateral pulmonary infiltrates, pulmonary
ADDRESSES. Webb-Waring Institute for Biomedical Research
(J. A. Leff, MD, C. E Day, BS, J. M. McCord, PhD, J. E. Repine, MD) and
Departments of Medicine and Surgery, Denver General
Hospital, University of Colorado (P. E Parsons, MD, F. A. Moore, MD,
E. E. Moore, MD), Denver, Colorado, USA; Department of
Biochemistry, Osaka University Medical School, Osaka, Japan
(N. Taniguchi, MD), and Department of Clinical Biochemistry,
University of Munich, Germany (M. Jochum, PhD, H. Fritz, PhD).
Correspondence to Dr Jonathan A. Leff, Webb-Waring Institute for
Biomedical Research, 4200 East Ninth Avenue, Box C322, Denver,
Colorado 80262, USA.
. = septic patients with ARDS ; .. = septic patients without ARDS; M = healthy controls. Points are means (SE) of
3-20 measurements
MnSOD= manganese superoxide dismutase; G PX= glutathione peroxidase; LDH = lactate dehydrogenase.
capillary wedge pressure below 18 mm Hg, static pulmonary
compliance below 50 mL/cm water, and ratio of arterial to alveolar
partial pressure of oxygen of less than 025.’1 Blood samples were
taken at the diagnosis ofsepsis (0 h) and also 6, 12,24, and 48 h later.
ARDS developed in 6 patients 6-24 h after the diagnosis of sepsis.
Samples were also obtained whenARDS was diagnosed and 6-24 h
later either through an indwelling arterial or venous catheter or by
direct venepuncture. All patients were prospectively and
sequentially studied until death or discharge. Assays were done by
staff unaware of the diagnoses. 15 healthy subjects were studied as
controls.
Manganese superoxide dismutase,12 factor VIII antigen" and
Pi-elastase complexes14 were measured by enzyme-linked
immunosorbent assays (ELISAs). The ELISA for manganese
superoxide dismutase had a sensitivity of2 ng/mL and a coefficient
of variation of less than 3%. Catalase was assayed by polarographic
measurement ofoxygen production;810 pL serum was added to 10
mmol/L hydrogen peroxide in 400L Hanks’ balanced salt solution
in an airtight, temperature-controlled chamber, which was stirred
continuously. Oxygen production was measured with an oxygen
electrode, calibrated daily. 1 U catalase activity was defined as the
amount of enzyme that consumed 1 Etmole of hydrogen peroxide
per min at 25&deg;C. The assay had a sensitivity ofabout 055 U/mL and
a coefficient of variation below 5%. Glutathione peroxidase was
measured spectrophotometrically by the oxidation of NADPH at
340 nm in glutathione reductase, glutathione, and t-butyl
hydroperoxide.15 Lactate dehydrogenasels and albumin were
assayed spectrophometrically and uric acid by high-performance
liquid chomatography.
Patients with and without ARDS and healthy controls were
compared by analysis of variance with a Student-Newman-Keuls
test of multiple comparisons. An unpaired t test was used to
compare the clinical characteristics of septic patients with and
without ARDS. For sensitivity, specificity, positive and negative
predictive values, and efficiency, 95 % CIs were calculated based on
the binomial distribution.
Results
The patients with and without ARDS were similar
(p>0-05) in terms of age, sex, packed-cell volume,
haemoglobin concentration, blood leucocyte and neutrophil
counts, serum alanine aminotransferase activity, serum
concentrations of bilirubin, albumin, and uric acid, and
APACHE II score, as reported previously.8,11 3 of the 6
patients in whom ARDS developed and 6 ofthe 20 without
ARDS died.
Patients with sepsis had higher serum manganese
superoxide dismutase concentrations than did control
subjects (figure). However, at the time ofdiagnosis of sepsis
(6-24 h before ARDS was diagnosed in 6 patients) the
patients who progressed to ARDS had higher serum
concentrations ofthis enzyme than did patients who did not
develop ARDS (p<0-05). The concentrations remained
high for the next 48 h in the ARDS group but returned to
control values in the non-ARDS patients. Similarly, at the
time ofdiagnosis ofsepsis, serum catalase activity was higher
in patients with sepsis than in control subjects (p < 0-05) and
in turn patients who later developed ARDS had higher
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(p < 005) serum catalase activity than the non-ARDS
patients (figure). During the next 48 h, serum catalase
activity increased progressively in patients who developed
ARDS but decreased in the other patients. By contrast, we
found no significant difference between control subjects and
sepsis patients with or without subsequent ARDS in serum
glutathione peroxidase activity.
Serum lactate dehydrogenase activity was also
significantly higher in patients who subsequently developed
ARDS than in patients who did not progress to ARDS
(p < 0-05); the latter had activities similar to those of the
controls. Lactate dehydrogenase activity increased during
the study period in sepsis patients who developed ARDS
but not in the other groups.
For factor VIII, serum concentrations were higher in
patients with sepsis than in the healthy controls but there
were no significant differences between septic patients with
and without ARDS. Plasma concentrations of cx1Pi-elastase
complexes also werehigher in septic patients than controls at
diagnosis of sepsis, but the difference between patients who
did and did not develop ARDS was significant (p < 0.05)
only when ARDS had been diagnosed.
We found no correlations at any time among the six
markers. When we calculated indices ofthe markers’ ability
to predict ARDS development, based on cutoff points
chosen by inspection of the data to provide the best
separation of ARDS and non-ARDS subjects, the positive
and negative predictive values and the sensitivity and
specificity of serum manganese superoxide dismutase
concentrations (above or equal to a cutoff of 450 ng/mL),
catalase activity (30 U/mL or above), lactate dehydrogenase
activity (250 U/L or above), and factor VIII concentrations
(445 % of control values or more) were similar in predicting
the development of ARDS in patients with sepsis (table).
Manganese superoxide dismutase, catalase, and lactate
dehydrogenase values exceeded the chosen cutoffvalues 9 h,
12 h, and 12 h, respectively, before ARDS was diagnosed.
Discussion
We have found that 9-12 h before the development of
ARDS, amounts of two serum antioxidant enzymes were
increased in sepsis patients who later developed ARDS
compared with patients who did not develop ARDS; both
factors predicted the development of ARDS in sepsis
patients with sensitivity, specificity, and efficiency equal to
those of lactate dehydrogenase and factor VIII
measurements.
Assessment of serum manganese superoxide dismutase
and catalase could be useful for defining the pathogenesis of
ARDS or for identifying patients with similar
characteristics. Each measurement is accessible, repeatable,
and easy to do. Use of these assessments could facilitate
study of prophylactic treatment by reducing the number of
at-risk patients needed. Our findings may also have
functional importance. These antioxidant enzymes can
diminish oxidant insults mediated by superoxide anion,
hydrogen peroxide, and their products such as hydroxyl
radicals. Accelerated intravascular generation of oxygen
radicals from stimulated neutrophils, circulating xanthine
oxidase, and other sources has been implicated in the
pathogenesis of sepsis and ARDS.’
Since the time courses for the various markers differed
and no two markers were intercorrelated, our findings
suggest that each factor represents a distinct process and that
the factors reflect various processes that occur in septic
patients with ARDS rather than in ARDS itself. This study
focused on sepsis-induced ARDS, and different
mechanisms may be present in ARDS that develops after
trauma or in other conditions. It is not clear where the
markers are produced. Lung tissue injury is a possible
source for higher than normal production of lactate
dehydrogenase, factor VIII, and the two antioxidant
enzymes. Endothelial cells are rich in these substances and,
if perturbed, could readily increase the amounts in blood.
However, intravascular neutrophil activation must bring
about increases in cx1Pi-elastase complexes, since elastase is
present only in neutrophils. Changes in cx1Pi-elastase
complexes occurred later than the other changes at diagnosis
of ARDS, and concentrations had fallen to normal by 48 h
after the diagnosis of sepsis, perhaps indicating a decline in
neutrophil activity. Red blood cell haemolysis is a plausible
source for increased amounts of serum catalase and lactate
dehydrogenase, but not manganese superoxide dismutase or
factor VIII. Serum catalase activity is increased in the serum
of rats subjected to skin bumSl6 and in patients with
acquired immunodeficiency syndromebut again the
source is unclear. High concentrations of interleukin-1,
tumour necrosis factor, and endotoxin have been found in
ARDS patients17 and can cause increases in antioxidants
such as manganese superoxide dismutase and catalase.18-20
Perhaps increases in antioxidants reflect activation of
intrinsic antioxidant tolerance mechanisms mediated by
cytokines.11
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